First, blockade of the endogenous ligands by HA PD-1 Ig and concomitant elimination of PD-1-mediated inhibitory signals at the effector T cell level may lead to increased T cell proliferation and elevated effector cytokine (e.g., IFN-γ) levels at the tumor site. Here, PDCD1 is linked to neoplasm.